期刊文献+

Toll样受体4基因启动子单核苷酸多态性对结直肠癌预后的影响 被引量:1

The prognostic significance of single nucleotide polymorphisms of Toll-like receptor 4 gene promoter in colorectal cancer
下载PDF
导出
摘要 目的 评估Toll样受体4(TLR4)基因启动子单核苷酸多态性(SNP)对结直肠癌预后的影响.方法 收集277例TNM分期Ⅰ~Ⅳ的结直肠癌患者.PCR扩增产物测序法测定结直肠癌患者外周血DNA的TLR4基因启动子SNP位点rs10983755和ss77136219 SNP的基因型,并计算其单倍体型.患者的总生存(OS)和疾病无进展(PFS)情况采用Kaplan-Meier法计算,单变量log-rank法比较SNP不同的基因型和单倍体型对OS和DFS情况的影响,Cox比例风险模型多变量分析对预后的影响.结果 rs10983755发生G→A突变,其基因型GG、GA和AA的频率分别是37.9%、33.9%和28.2%;ss77136219发生A→G突变,其基因型AA、AG、GG的频率分别是41.2%、27.8%和31.0%.两位点多态性符合Hardy-Weinberg平衡(P〉0.05),具有较强的连锁不平衡(R=0.58,D′=0.74),其单倍体型GA、GG、AG和AA频率分别为37.2%、11.5%、22.6%和28.7%.全部结直肠癌患者的5年OS率和PFS率分别为68.4%和60.9%.单变量分析显示,rs10983755和ss77136219不同的基因型均具有明显不同的OS率和PFS率(P〈0.001).在校正年龄、性别、肿瘤部位、手术方式、组织学分级、TNM分期和辅助化疗后,Cox多变量生存分析显示rs10983755和ss77136219不同的基因型和单倍体型同样具有明显不同的OS和PFS情况(P〈0.05).结论 TLR4基因启动子的SNP是结直肠癌的独立预后因素. Objective To evaluate the prognostic significance of single nucleotide polymorphisms (SNP) of Toll - like receptor 4 (TLR4) gene promoter in coiotectal cancer. Methods Genotypes and haplotypes analysis of TLR4 promoter SNP rs10983755 and ss77136219 were performed by the direct sequencing of PCR products using DNA from whole blood of 227 patients with colorectal cancer. The survival estimates were calculated using the Kaplan - Meier method. The differences in overall survival (OS) or progressionfree survival (PFS) according to the different genotypes were compared using log - rank tests. Cox proportional hazard model was used for the multivariate survival analyses. Results Gene mutation of G→A in rs10983755 were identified for three genotype GG, GA and AA, with the frequencies of 37.9%, 33.9% and 28.2%, respectively; while the genotype frequencies of AA, AG and GG in ss77136219 with the mutation of A→G were 41.2%, 27.8% and 31.0%, respectively. The genotype frequencies of rs10983755 and ss77136219 were conformed to Hardy - Weinberg equilibrium ( P 〉 0. 05 ) and exhibited strong linkage disequilibrium ( R = 0. 58, D' = 0. 74). The 5 -year OS and PFS were 68.4% and 60. 9% , respectively. In univariate analysis, all TLR4 gene polymorphisms had significant effect on OS and PFS (P 〈 0. 001 ). According to multivariate Cox model, adjusted for age, sex, site of tumor, surgical resection, differentiation, stage, and adjuvant chemotherapy, there were significant differences in OS and PFS between rs10983755 and ss77136219 (P 〈0. 05). Conclusion SNP of TLR4 promoter is independent prognostic factor of colorectal cancer.
出处 《广东医学》 CAS CSCD 北大核心 2013年第23期3573-3577,共5页 Guangdong Medical Journal
基金 广东省医学科研基金资助项目(编号:A2011260)
关键词 结直肠癌 Toll样受体4基因 启动子 单核苷酸多态性 预后 colorectal cancer Toll- like receptor 4 gene promoter single nucleotide polymorphisms prognosis
  • 相关文献

参考文献19

  • 1WU S,RHEE K J,ALBESIANO E. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses[J].{H}Nature Medicine,2009,(09):1016-1022.
  • 2BISWAS A,WILMANSKI J,FORSMAN H. Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine[J].{H}European Journal of Immunology,2011,(01):182-194.
  • 3CAMMAROTA R,BERTOLINI V,PENNESI G. The tumor microenvironment of colorectal cancer:stromal TLR-4 expression as a potential prognostic marker[J].{H}Journal of Translational Medicine,2010,(08):112-128.
  • 4SLATTERY M L,HERRICK J S,BONDURANT K L. Toll-like receptor genes and their association with colon and rectal can cer development and prognosis[J].{H}International Journal of Cancer,2012,(12):2974-2980.
  • 5万德森,陈功.结直肠癌的流行病学及其危险因素研究近况[J].实用癌症杂志,2000,15(2):220-222. 被引量:103
  • 6FERLAY J,PARKIN D M,STELIAROVA FOUCHER E. Estimates of cancer incidence and mortality in Europe in 2008[J].{H}EUROPEAN JOURNAL OF CANCER,2010,(04):765-781.
  • 7HOLD G L,RABKIN C S,CHOW W H. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors[J].{H}GASTROENTEROLOGY,2007,(03):905-912.
  • 8SHUI I M,STARK J R,PENNEY K L. Genetic variation in the Toll-like receptor 4 and prostate cancer incidence and morta lity[J].{H}PROSTATE,2012,(02):209-216.
  • 9YANG C X,LI C Y,FENG W. Toll-like receptor 4 genetic variants and prognosis of breast cancer[J].{H}Tissue Antigens,2013,(04):221-226.
  • 10EYKING A,EY B,RUNZI M. Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer[J].{H}GASTROENTEROLOGY,2011,(06):2154-2165.

二级参考文献6

共引文献102

同被引文献24

  • 1LEE C C, ANVALOS A M, PLOEGH H L. Accessory molecules for Toll - like receptors and their functio[ J]. Nat Rev Immunol, 2012, 12(3): 168-179.
  • 2KIM E J, CHUNG W C, LEE K M, et al. Association between Toll - like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population[ J]. J Korean Med Sci, 2012, 27(1) : 72 -77.
  • 3SHCHEBLYAKOV D V, LOGUNOV D Y, TUKHVATULIN A I, et al. Toll -like receptors (TLRs) : the role in tumor progression [J]. Acta Naturae, 2010, 2(3) : 21 -29.
  • 4YU C, SHAN T, FENG A, et al. Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF - kappaB signaling pathway[ Jl. Fitoterapia, 2011, 82(4) : 709 -715.
  • 5BASITH S, MANAVALAN B, YOO T H, et al. Roles of Toll - like receptors in cancer: a double - edged sword for defense and offense[J]. Arch Pharm Res, 2012, 35(8) : 1297 -1316.
  • 6LU Q, DING H, LI W. Role of Toll - like receptors in microbiota - associated gastrointestinal cancer metastasis [ J 1 J Cancer Res Ther, 2013, 9 Suppl: S142-S149.
  • 7SUN S, WANG X, WU X, et al. Toll - like receptor activation by helminths or helminth products to alleviate inflammatory bowel dis- ease[J]. Parasit Vectors, 2011,4: 186.
  • 8SEWELL G W, RAHMAN F Z, LEVINE A P, et al. Defective tumor necrosis factor release from Crohn's disease macrophages in response to Toll - like receptor activation: relationship to pheno- type and genome -wide association susceptibility loci[J]. Inflamm Bowel Dis, 2012, 18(11 ) : 2120 -2127.
  • 9BERKOW1TZ D, PERI R, LAVY A, et al. Increased Toll - like receptor 9 expression by B cells from inflammatory bowel disease patients[Jl. Hum Immunol, 2013, 74(12) : 1519 - 1523.
  • 10RAKHESH M, CATE M, VIJAY R, et al. A TLR4 - interacting peptide inhibits lipopolysaceharide - stimulated inflammatory re- sponses, migration and invasion of colon cancer SW480 cells [ J ]. Oncoimmunology, 2012, 1 (9) : 1495 - 1506.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部